Lipigon Pharmaceuticals AB:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Lipigon Pharmaceuticals AB - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C11221
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:17
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:スウェーデン
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Lipigon Pharmaceuticals AB (Lipigon Pharmaceuticals) is a lipid biology company that discovers and develops novel therapies for lipid disorders and other cardiometabolic risk factors. The company offers developing its products in various therapeutic areas such as cardiovascular and metabolic disorders. It discovers small molecule activators of lipoprotein lipase. Lipigon Pharmaceuticals’ lead product candidate is designed to significantly lower the elevated levels of TG, raise levels of HDL and improve other cardiometabolic risk factors. The company partners with other pharmaceutical companies to develop new projects. Lipigon Pharmaceuticals is headquartered in Umea, Sweden.

Lipigon Pharmaceuticals AB – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Lipigon Pharmaceuticals AB, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Lipigon Pharmaceuticals AB, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Lipigon Pharmaceuticals AB, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Lipigon Pharmaceuticals AB, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Lipigon Pharmaceuticals AB, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Lipigon Pharmaceuticals AB, Pharmaceuticals & Healthcare, Deal Details 10
Partnerships 10
Lipigon Pharma Enters into Agreement with Secarna Pharma 10
Lipigon Pharma Enters into Research Agreement with AstraZeneca 11
Lipigon Pharma Enters into Research Collaboration Agreement with AstraZeneca 12
Lipigon Pharmaceuticals AB – Key Competitors 13
Lipigon Pharmaceuticals AB – Key Employees 14
Lipigon Pharmaceuticals AB – Locations And Subsidiaries 15
Head Office 15
Recent Developments 16
Corporate Communications 16
Apr 06, 2017: Lipigon Pharmaceuticals announces new appointed members of the board – Gisela Sitbon and Erik Lund 16
Appendix 17
Methodology 17
About GlobalData 17
Contact Us 17
Disclaimer 17

List of Tables
Lipigon Pharmaceuticals AB, Pharmaceuticals & Healthcare, Key Facts 2
Lipigon Pharmaceuticals AB, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Lipigon Pharmaceuticals AB, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Lipigon Pharmaceuticals AB, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Lipigon Pharmaceuticals AB, Deals By Therapy Area, 2012 to YTD 2018 8
Lipigon Pharmaceuticals AB, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Lipigon Pharma Enters into Agreement with Secarna Pharma 10
Lipigon Pharma Enters into Research Agreement with AstraZeneca 11
Lipigon Pharma Enters into Research Collaboration Agreement with AstraZeneca 12
Lipigon Pharmaceuticals AB, Key Competitors 13
Lipigon Pharmaceuticals AB, Key Employees 14

List of Figures
Lipigon Pharmaceuticals AB, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Lipigon Pharmaceuticals AB, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Lipigon Pharmaceuticals AB, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Lipigon Pharmaceuticals AB, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Lipigon Pharmaceuticals AB, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Lipigon Pharmaceuticals AB, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Lipigon Pharmaceuticals AB, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Lipigon Pharmaceuticals AB, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

★海外企業調査レポート[Lipigon Pharmaceuticals AB:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Royal College of Surgeons Ireland:製薬・医療:M&Aディール及び事業提携情報
    Summary Royal College of Surgeons Ireland (RCSI) is an educational institution that offers medical education and training in healthcare professions at undergraduate and postgraduate levels. The institute provides undergraduate courses in nursing, postgraduate research, leadership courses, and surgic …
  • Hillenbrand Inc (HI):企業の財務・戦略的SWOT分析
    Hillenbrand Inc (HI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Telephonics Corporation:企業の戦略的SWOT分析
    Telephonics Corporation - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products an …
  • Swedbank AB:企業のM&A・事業提携・投資動向
    Swedbank AB - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Swedbank AB Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, ca …
  • EnerWorks Inc.:企業の戦略的SWOT分析
    EnerWorks Inc. - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and service …
  • EBTEC Corporation:企業の戦略・SWOT・財務分析
    EBTEC Corporation - Strategy, SWOT and Corporate Finance Report Summary EBTEC Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • China Vanke Co., Ltd.:企業の戦略・SWOT・財務情報
    China Vanke Co., Ltd. - Strategy, SWOT and Corporate Finance Report Summary China Vanke Co., Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Helios and Matheson Analytics Inc (HMNY):企業の財務・戦略的SWOT分析
    Summary Helios and Matheson Analytics Inc (Helios and Matheson) is a big data company. It offers IT infrastructure, social data aggregation, cognitive computing, map-tech innovation, application development, pattern discovery solutions. The company's analytic solutions find application across a broa …
  • KAMCO Investment Co KSCP (KAMCO):企業の財務・戦略的SWOT分析
    KAMCO Investment Co KSCP (KAMCO) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and wea …
  • Subaru Corp (7270):企業の財務・戦略的SWOT分析
    Subaru Corp (7270) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and th …
  • FMC Corp (FMC):企業の財務・戦略的SWOT分析
    FMC Corp (FMC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the po …
  • University of Michigan-製薬・医療分野:企業M&A・提携分析
    Summary University of Michigan (UM) is an educational service provider that offers educational and research services. The university offers graduate, undergraduate and post-doctoral levels programs in various disciplines. It operates various graduate schools and colleges of graduate studies, archite …
  • Midea Group Co Ltd:企業の戦略・SWOT・財務情報
    Midea Group Co Ltd - Strategy, SWOT and Corporate Finance Report Summary Midea Group Co Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Chesapeake Energy Corporation:企業の戦略・SWOT・財務情報
    Chesapeake Energy Corporation - Strategy, SWOT and Corporate Finance Report Summary Chesapeake Energy Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and …
  • Getlink SE (GET):企業の財務・戦略的SWOT分析
    Getlink SE (GET) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • GlaxoSmithKline Plc (GSK)-製薬・医療分野:企業M&A・提携分析
    Summary GlaxoSmithKline Plc (GSK) is a healthcare company, which focuses on the development, manufacture and commercialization of pharmaceuticals, vaccines and consumer healthcare products. It offers drugs for the treatment of respiratory, cancer, cardiovascular, HIV and infectious diseases, respira …
  • Richter Gedeon Nyrt (RICHTER)-医療機器分野:企業M&A・提携分析
    Summary Richter Gedeon Nyrt (Richter) is a pharmaceutical company that develops, manufactures and commercializes a wide range of drugs including original, generic and licensed products and over-the-counter (OTC) medicines. The company’s product portfolio encompasses medicines to treat gynaecological …
  • Plantic Technologies Ltd:企業の戦略的SWOT分析
    Plantic Technologies Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products a …
  • ABF Ingredients Ltd:企業の戦略・SWOT・財務情報
    ABF Ingredients Ltd - Strategy, SWOT and Corporate Finance Report Summary ABF Ingredients Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • China Sunshine Paper Holdings Company Limited:企業の戦略・SWOT・財務情報
    China Sunshine Paper Holdings Company Limited - Strategy, SWOT and Corporate Finance Report Summary China Sunshine Paper Holdings Company Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, opera …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆